Anuh Pharma (BOM:506260) Debt-to-Asset : 0.00 (As of Jun. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Anuh Pharma Debt-to-Asset?

Anuh Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₹0 Mil. Anuh Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was ₹0 Mil. Anuh Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was ₹0 Mil.

Anuh Pharma Debt-to-Asset Historical Data

The historical data trend for Anuh Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anuh Pharma Debt-to-Asset Chart

Anuh Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

Get a 7-Day Free Trial

0.14

0.04

0.01

Anuh Pharma Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															-	0.02	-	0.01	-

Competitive Comparison of Anuh Pharma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Anuh Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anuh Pharma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anuh Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Anuh Pharma's Debt-to-Asset falls into.

Anuh Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Anuh Pharma's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(23.045	+	3.883)	/	4456.8
	=	0.01

Anuh Pharma's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0	+	0)	/	0
	=	N/A

Anuh Pharma (BOM:506260) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Anuh Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Anuh Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Anuh Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anuh Pharma Ltd (BOM:506260) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

Dr. Annie Besant Road, North Wing, 3-A, Shiv Sagar Estate, Worli, Mumbai, MH, IND, 400 018

Website

https://www.anuhpharma.com

Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.

Anuh Pharma Headlines

No Headlines